Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
US-10821111-B2 · Nov 3, 2020 · US
Cross-Sectional Technologies
Cross-Sectional Technologies · Cooperative Patent Classification (CPC)
General tagging of emerging or interdisciplinary technologies.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | Y02A50/465 |
| Official title | — |
| Display label | Cross-Sectional Technologies (mapped technology topic) |
| Total patents | 55 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity appears to be declining based on the most recent years.
| Year | Patents |
|---|---|
| 2018 | 8 |
| 2019 | 26 |
| 2020 | 21 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Engineered oncolytic viruses containing hyper-binding sites to sequester and suppress activity of oncogenic transcription factors as a novel treatment for human cancer
US-10813957-B2 · Oct 27, 2020 · US
Oncolytic poliovirus for human tumors
US-10799543-B2 · Oct 13, 2020 · US
Method of inhibiting or reducing a coronaviridae virus infection
US-2020317668-A1 · Oct 8, 2020 · US
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US-2020282061-A1 · Sep 10, 2020 · US
Pharmaceutical composition containing pyridylaminoacetic acid compound
US-10765750-B2 · Sep 8, 2020 · US
Two-dimensional polymeric structures and method for producing thereof
US-10758492-B2 · Sep 1, 2020 · US
Compositions and methods for inhibiting expression of CD274/PD-L1 gene
US-10745704-B2 · Aug 18, 2020 · US
Sequential anti-cancer treatment
US-10744171-B2 · Aug 18, 2020 · US
Nuclear transport modulators and uses thereof
US-10722497-B2 · Jul 28, 2020 · US
Nuclear transport modulators and uses thereof
US-2020230110-A1 · Jul 23, 2020 · US
Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections
US-2020206229-A1 · Jul 2, 2020 · US
1,2,4-Oxadiazole Derivatives as Immunomodulators
US-2020199086-A1 · Jun 25, 2020 · US
Methods for modulating RNA splicing
US-10668171-B2 · Jun 2, 2020 · US
Genetic engineering of macrophages for immunotherapy
US-2020155597-A1 · May 21, 2020 · US
Composition comprising tetracyclic compound
US-10646468-B2 · May 12, 2020 · US
Pyridylaminoacetic acid compound and polyoxyethylene castor oil-containing pharmaceutical composition
US-2020113880-A1 · Apr 16, 2020 · US
Nuclear transport modulators and uses thereof
US-10617677-B2 · Apr 14, 2020 · US
1,2,4-oxadiazole derivatives as immunomodulators
US-10590093-B2 · Mar 17, 2020 · US
Methods and compositions for RNAi mediated inhibition of gene expression in mammals
US-10590418-B2 · Mar 17, 2020 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC Y02A50/465?
- CPC Y02A50/465 is the Cooperative Patent Classification code for “Cross-Sectional Technologies.”
- How many patents are filed under CPC Y02A50/465 (Cross-Sectional Technologies)?
- Our database includes 55 publications tagged with this CPC code.
- Is patent activity under CPC Y02A50/465 growing?
- Publication counts under this code: 26 in 2019 vs 21 in 2020 (latest complete years).